These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 34053234)
1. Ligustilide counteracts carcinogenesis and hepatocellular carcinoma cell-evoked macrophage M2 polarization by regulating yes-associated protein-mediated interleukin-6 secretion. Yang J; Xing Z Exp Biol Med (Maywood); 2021 Sep; 246(17):1928-1937. PubMed ID: 34053234 [TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis. Wang X; Gao S; Song L; Liu M; Sun Z; Liu J Mol Immunol; 2021 Feb; 130():113-121. PubMed ID: 33308900 [TBL] [Abstract][Full Text] [Related]
3. IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma. Yin Z; Ma T; Lin Y; Lu X; Zhang C; Chen S; Jian Z J Cell Biochem; 2018 Nov; 119(11):9419-9432. PubMed ID: 30015355 [TBL] [Abstract][Full Text] [Related]
4. Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization. Zhao X; Wang X; You Y; Wen D; Feng Z; Zhou Y; Que K; Gong J; Liu Z Exp Cell Res; 2020 Jun; 391(1):111979. PubMed ID: 32246992 [TBL] [Abstract][Full Text] [Related]
5. Phellinus linteus activates Treg cells via FAK to promote M2 macrophage polarization in hepatocellular carcinoma. Chen F; Gong M; Weng D; Jin Z; Han G; Yang Z; Han J; Wang J Cancer Immunol Immunother; 2024 Jan; 73(1):18. PubMed ID: 38240856 [TBL] [Abstract][Full Text] [Related]
6. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors. Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048 [TBL] [Abstract][Full Text] [Related]
7. Exosomal SLC16A1-AS1-induced M2 macrophages polarization facilitates hepatocellular carcinoma progression. Hu Y; Li Y; Xiong H; Zhang Y; Wang F; Zhuo W; Zeng Z; Zhao Y; Wang H; Hu P; Han S; Huang Y; Lv G; Zhao G Int J Biol Sci; 2024; 20(11):4341-4363. PubMed ID: 39247822 [TBL] [Abstract][Full Text] [Related]
8. Bufalin suppresses hepatocellular carcinogenesis by targeting M2 macrophage-governed Wnt1/β-catenin signaling. Zhang X; Lu X; Shi J; Li Y; Li Y; Tao R; Huang L; Tang Y; Zhu X; Li M; Gao Y; Feng H; Yu Z Phytomedicine; 2024 Apr; 126():155395. PubMed ID: 38340578 [TBL] [Abstract][Full Text] [Related]
9. Knockdown of liver cancer cell-secreted exosomal PSMA5 controls macrophage polarization to restrain cancer progression by blocking JAK2/STAT3 signaling. Xie S; Li X; Yan J; Yu H; Chen S; Chen K Immun Inflamm Dis; 2024 Feb; 12(2):e1146. PubMed ID: 38415977 [TBL] [Abstract][Full Text] [Related]
10. Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment. Li Q; Ma L; Shen S; Guo Y; Cao Q; Cai X; Feng J; Yan Y; Hu T; Luo S; Zhou L; Peng B; Yang Z; Hua Y J Exp Clin Cancer Res; 2019 Jul; 38(1):303. PubMed ID: 31296243 [TBL] [Abstract][Full Text] [Related]
11. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis. Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401 [TBL] [Abstract][Full Text] [Related]
12. Exosomal lncRNA HEIH, an essential communicator for hepatocellular carcinoma cells and macrophage M2 polarization through the miR-98-5p/STAT3 axis. Ai JH; Wen YZ; Dai SJ; Zhang LD; Huang ZJ; Shi J J Biochem Mol Toxicol; 2024 Apr; 38(4):e23686. PubMed ID: 38549433 [TBL] [Abstract][Full Text] [Related]
13. β,β-Dimethylacrylalkannin, a Natural Naphthoquinone, Inhibits the Growth of Hepatocellular Carcinoma Cells by Modulating Tumor-Associated Macrophages. Shen LS; Lin Z; Gong RH; Lin YS; Qiao XF; Hu QM; Qin WH; Chen S; Yang Y; Chen GQ Molecules; 2024 Aug; 29(16):. PubMed ID: 39202998 [TBL] [Abstract][Full Text] [Related]
14. PLXDC1 serves as a potential prognostic marker and involves in malignant progression and macrophage polarization in colon cancer. Fu Y; Zhang X; Qiao Q J Biochem Mol Toxicol; 2024 Oct; 38(10):e23832. PubMed ID: 39267413 [TBL] [Abstract][Full Text] [Related]
15. Cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway. Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849 [TBL] [Abstract][Full Text] [Related]
16. [Apatinib Suppressed Macrophage-Mediated Malignant Behavior of Hepatocellular Carcinoma Cells via Modulation of VEGFR2/STAT3/PD-L1 Signaling]. Yin T; Fu CB; Wu DD; Nie L; Chen H; Wang Y Mol Biol (Mosk); 2023; 57(4):706-708. PubMed ID: 37528791 [TBL] [Abstract][Full Text] [Related]
17. Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion. Sprinzl MF; Puschnik A; Schlitter AM; Schad A; Ackermann K; Esposito I; Lang H; Galle PR; Weinmann A; Heikenwälder M; Protzer U J Hepatol; 2015 Apr; 62(4):863-70. PubMed ID: 25463538 [TBL] [Abstract][Full Text] [Related]
18. The mechanism of lncRNA-CRNDE in regulating tumour-associated macrophage M2 polarization and promoting tumour angiogenesis. Han C; Yang Y; Sheng Y; Wang J; Li W; Zhou X; Guo L J Cell Mol Med; 2021 May; 25(9):4235-4247. PubMed ID: 33742511 [TBL] [Abstract][Full Text] [Related]
19. Hsa_circ_0010882 facilitates hepatocellular carcinoma progression by modulating M1/M2 macrophage polarization. Yang M; Yu T; Han L J Viral Hepat; 2024 Apr; 31(4):189-196. PubMed ID: 38235909 [TBL] [Abstract][Full Text] [Related]
20. Cinobufacini injection delays hepatocellular carcinoma progression by regulating lipid metabolism via SREBP1 signaling pathway and affecting macrophage polarization. Wang M; Li Y; Li S; Wang T; Wang M; Wu H; Zhang M; Luo S; Zhao C; Li Q; Cheng H J Ethnopharmacol; 2024 Mar; 321():117472. PubMed ID: 37995825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]